These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23385394)

  • 1. Citalopram-associated gambling: a case report.
    Cuomo I; Kotzalidis GD; Caccia F; Danese E; Manfredi G; Girardi P
    J Gambl Stud; 2014 Jun; 30(2):467-73. PubMed ID: 23385394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.
    Fava M; Rush AJ; Alpert JE; Balasubramani GK; Wisniewski SR; Carmin CN; Biggs MM; Zisook S; Leuchter A; Howland R; Warden D; Trivedi MH
    Am J Psychiatry; 2008 Mar; 165(3):342-51. PubMed ID: 18172020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
    Aragona M; Bancheri L; Perinelli D; Tarsitani L; Pizzimenti A; Conte A; Inghilleri M
    Eur J Pain; 2005 Feb; 9(1):33-8. PubMed ID: 15629872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases].
    Richard MA; Fiszenson F; Jreissati M; Jean Pastor MJ; Grob JJ
    Ann Dermatol Venereol; 2001; 128(6-7):759-61. PubMed ID: 11460042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label study of citalopram in the treatment of pathological gambling.
    Zimmerman M; Breen RB; Posternak MA
    J Clin Psychiatry; 2002 Jan; 63(1):44-8. PubMed ID: 11838625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delirium during i. v. citalopram treatment: a case report.
    Delić M; Pregelj P
    Pharmacopsychiatry; 2013 Jan; 46(1):37-8. PubMed ID: 22821385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine.
    Landén M; Högberg P; Thase ME
    J Clin Psychiatry; 2005 Jan; 66(1):100-6. PubMed ID: 15669895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression.
    Hieronymus F; Lisinski A; Nilsson S; Eriksson E
    Mol Psychiatry; 2018 Aug; 23(8):1731-1736. PubMed ID: 29155804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of citalopram plus paliperidone is better than citalopram alone in the treatment of somatoform disorder: results of a 6-week randomized study.
    Huang M; Luo B; Hu J; Wei N; Chen L; Wang S; Zhou W; Hu S; Xu Y
    Int Clin Psychopharmacol; 2012 May; 27(3):151-8. PubMed ID: 22367417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SSRI-induced akathesia].
    Hofmann M; Vidoni F
    Psychiatr Prax; 1996 May; 23(3):143-4. PubMed ID: 8711007
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.
    Amitai M; Kronenberg S; Carmel M; Michaelovsky E; Frisch A; Brent D; Apter A; Chen A; Weizman A; Fennig S
    J Neural Transm (Vienna); 2016 Nov; 123(11):1347-1354. PubMed ID: 27324805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and acceptability of sertraline and citalopram in major depressive disorder: pragmatic randomized open-label comparison.
    Matreja PS; Badyal DK; Khosla P; Deswal RS
    Hum Psychopharmacol; 2007 Oct; 22(7):477-82. PubMed ID: 17647298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram-induced photopigmentation.
    Inalöz HS; Kirtak N; Herken H; Ozgöztaşi O; Aynacioğlu AS
    J Dermatol; 2001 Dec; 28(12):742-5. PubMed ID: 11804072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panic attacks associated with citalopram.
    Brauer HR; Nowicki PW; Catalano G; Catalano MC
    South Med J; 2002 Sep; 95(9):1088-9. PubMed ID: 12356120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
    McGrath PJ; Khan AY; Trivedi MH; Stewart JW; Morris DW; Wisniewski SR; Miyahara S; Nierenberg AA; Fava M; Rush AJ
    J Clin Psychiatry; 2008 Dec; 69(12):1847-55. PubMed ID: 19026268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.